Stock listing
A403NH Stock Price, News, Filings & Events — Matinas Biopharma Holdings, Inc.
Selected listing: A403NH · LS · EUR · DE
This page tracks Matinas Biopharma Holdings, Inc.'s A403NH:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A403NH:LS. A403NH:LS is the stock-level entry point for investors researching Matinas Biopharma Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Matinas Biopharma Holdings, Inc. (ticker: MTNB) is a public company based in America with a market capitalization of approximately $4.7 million. The company focuses on developing innovative therapies to improve patient outcomes. Matinas is committed to advancing its proprietary drug delivery technologies to address unmet medical needs.
- Ticker
- A403NH:LS
- Asset type
- Stock
- Market cap
- $2.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Matinas Biopharma Holdings, Inc. A403NH:LS stock context
This page tracks Matinas Biopharma Holdings, Inc.'s A403NH:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A403NH:LS. A403NH:LS is the stock-level entry point for investors researching Matinas Biopharma Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Matinas Biopharma Holdings, Inc. (ticker: MTNB) is a public company based in America with a market capitalization of approximately $4.7 million. The company focuses on developing innovative therapies to improve patient outcomes. Matinas is committed to advancing its proprietary drug delivery technologies to address unmet medical needs.
Latest news from Matinas Biopharma Holdings, Inc.
Matinas BioPharma : Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hyd...
July 13, 2026
Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydro...
July 13, 2026
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compl...
June 26, 2026
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
April 3, 2026
Matinas BioPharma : Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction Form 8 K
October 31, 2024
Matinas Biopharma Holdings, Inc. earnings calls
Matinas Biopharma Holdings, Inc. (MTNB) Q2 2024 Earnings Call
August 14, 2024 · Replay with transcript and chapters
Matinas Biopharma Holdings, Inc. (MTNB) Q1 2024 Earnings Call
May 9, 2024 · Replay with transcript and chapters
Matinas Biopharma Holdings, Inc. (MTNB) Q3 2023 Earnings Call
November 8, 2023 · Replay with transcript and chapters
Matinas Biopharma Holdings, Inc. (MTNB) Q2 2023 Earnings Call
August 9, 2023 · Replay with transcript and chapters
Matinas Biopharma Holdings, Inc. (MTNB) Q1 2023 Earnings Call
May 10, 2023 · Replay with transcript and chapters
Matinas Biopharma Holdings, Inc. (MTNB) Q4 2022 Earnings Call
March 15, 2023 · Replay with transcript and chapters
Research Matinas Biopharma Holdings, Inc.
Matinas Biopharma Holdings, Inc. investor report
Review AI stock analysis and investor report context for A403NH:LS.
Matinas Biopharma Holdings, Inc. company profile
View the public company page for Matinas Biopharma Holdings, Inc. on 6ix.
Matinas Biopharma Holdings, Inc. news
Read company news and market updates connected to Matinas Biopharma Holdings, Inc..
Matinas Biopharma Holdings, Inc. investor events
Find investor webinars, events, and replay context for Matinas Biopharma Holdings, Inc..
Alternate listings
MTNB:AMEX
US · USD
Alternate listing for Matinas Biopharma Holdings, Inc.; the primary context on this page is A403NH:LS.
MTNB:BOATS
US · USD
Alternate listing for Matinas Biopharma Holdings, Inc.; the primary context on this page is A403NH:LS.
6LJ0:FWB
DE · EUR
Alternate listing for Matinas Biopharma Holdings, Inc.; the primary context on this page is A403NH:LS.
6LJ0:GETTEX
DE · EUR
Alternate listing for Matinas Biopharma Holdings, Inc.; the primary context on this page is A403NH:LS.
6LJ0:MUN
DE · EUR
Alternate listing for Matinas Biopharma Holdings, Inc.; the primary context on this page is A403NH:LS.